Drug-Eluting Stents in the Perioperative Period: What Are the Key Aspects in Management?

Abstract

Get full access to this article

View all access options for this article.

References

Fleisher LA

Beckman JA

Brown KA

, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coll Cardiol. 2007;50: 1707-1732.

Practice alert for the perioperative management of patients with coronary artery stents: a report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology . 2009;110:22-23.

Grines CL

Bonow RO

Casey DE Jr

, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians . Circulation. 2007;115:813-818.

King SB III

Smith SC Jr

Hirshfeld JW Jr

, et al. 2007focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol. 2008;51:172-209.

Barash P.

Akhtar S.

Coronary stents: factors contributing to perioperative major adverse cardiovascular events. Br J Anaesth.2010;105(suppl 1):i3-i15.

Rade JJ

Hogue CW Jr.

Noncardiac surgery for patients with coronary artery stents: timing is everything . Anesthesiology. 2008;109:573-575.

Brilakis ES

Banerjee S.

Berger PB

Perioperative management of patients with coronary stents. J Am Coll Cardiol. 2007;49:2145-2150.

Laskey WK

Yancy CW

Maisel WH

Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006 . Circulation. 2007;115:2352-2357.

Popescu WM

Perioperative management of the patient with a coronary stent. Curr Opin Anaesthesiol. 2010;23: 109-115.

10.

Newsome LT

Weller RS

Gerancher JC

Kutcher MA

Royster RL

Coronary artery stents: II. Perioperative considerations and management. Anesth Analg.2008;107:570-590.

11.

Iakovou I.

Schmidt T.

Bonizzoni E.

, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126-2130.

12.

Llau JV

López-Forte C.

Sapena L.

Ferrandis R.

Perioperative management of antiplatelet agents in noncardiac surgery. Eur J Anaesthesiol. 2009;26:181-187. doi:10.1097/ EJA.0b013e328324b79f.

13.

Thachil J.

Gatt A.

Martlew V.

Management of surgical patients receiving anticoagulation and antiplatelet agents. Br J Surg. 2008;95:1437-1448.

14.

Keeley E.

Boura J.

Grines C.

Primary coronary angioplasty versus intravenous fibrinolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20.